<DOC>
	<DOCNO>NCT02376621</DOCNO>
	<brief_summary>The study evaluate bioavailability omega-3 base dietary supplement fast condition healthy adult subject . Each subject participate 5 treatment period . The order treatment accordance randomisation schedule.There minimum 4 treatment-free day treatment period . On dose occasion , subject fast least 10 hour overnight , prior morning dosing . Twenty-four subject enrol complete dose 20 subject .</brief_summary>
	<brief_title>Bioavailability Omega-3 Food Supplements Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>male females ethnic origin age 40 65 year BMI 18.5 30.0 kg/m2 generally good health sign informed consent male female willing use appropriate contraception prescribe systemic topical medication take within 14 day take supplement contain omega3 faty acid fish oil last 14 day nonprescribed systemic topical medication include herbal remedy vitamin/mineral supplement within 7 day take medication include St. John 's Worth know alter drug absorption within 30 day subject participate clinical study past 3 month recent blood donation significant history drug allergy allergic disease allergy hypersensitivity omega3 fatty acid , fish , soya , oleic acid , sesame oil constituent pharmaceutical preparation . high consumption tobacco high consumption alcohol significant medical history physical finding ( include HIV , hepatitis ) vegetarians willing follow dietary restriction frequent migraine attack previously take part withdrawn study accord investigator participate .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>omega-3 base dietary supplement</keyword>
	<keyword>Bioavailability</keyword>
</DOC>